These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28501439)

  • 1. Paclitaxel: What has been done and the challenges remain ahead.
    Bernabeu E; Cagel M; Lagomarsino E; Moretton M; Chiappetta DA
    Int J Pharm; 2017 Jun; 526(1-2):474-495. PubMed ID: 28501439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What nanomedicine in the clinic right now really forms nanoparticles?
    Svenson S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay.
    Hwang D; Vinod N; Skoczen SL; Ramsey JD; Snapp KS; Montgomery SA; Wang M; Lim C; Frank JE; Sokolsky-Papkov M; Li Z; Yuan H; Stern ST; Kabanov AV
    Biomaterials; 2021 Nov; 278():121140. PubMed ID: 34634661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
    Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
    Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel drug delivery systems.
    Zhang Z; Mei L; Feng SS
    Expert Opin Drug Deliv; 2013 Mar; 10(3):325-40. PubMed ID: 23289542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current strategies for different paclitaxel-loaded Nano-delivery Systems towards therapeutic applications for ovarian carcinoma: A review article.
    Khalifa AM; Elsheikh MA; Khalifa AM; Elnaggar YSR
    J Control Release; 2019 Oct; 311-312():125-137. PubMed ID: 31476342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology - From Drug Discovery to Nanocarrier Design and Development.
    Sunoqrot S; Hamed R; Abdel-Halim H; Tarawneh O
    Curr Top Med Chem; 2017; 17(13):1451-1468. PubMed ID: 28017147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer.
    Park IH; Sohn JH; Kim SB; Lee KS; Chung JS; Lee SH; Kim TY; Jung KH; Cho EK; Kim YS; Song HS; Seo JH; Ryoo HM; Lee SA; Yoon SY; Kim CS; Kim YT; Kim SY; Jin MR; Ro J
    Cancer Res Treat; 2017 Jul; 49(3):569-577. PubMed ID: 27618821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionically fixed polymeric nanoparticles as a novel drug carrier.
    Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
    Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer.
    Xiao W; Suby N; Xiao K; Lin TY; Al Awwad N; Lam KS; Li Y
    J Control Release; 2017 Oct; 264():169-179. PubMed ID: 28847739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanodrugs: pharmacokinetics and safety.
    Onoue S; Yamada S; Chan HK
    Int J Nanomedicine; 2014; 9():1025-37. PubMed ID: 24591825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics.
    Videira MA; Arranja AG; Gouveia LF
    Eur J Pharm Sci; 2013 May; 49(2):302-10. PubMed ID: 23528739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High systemic availability of core-crosslinked polymeric micelles after subcutaneous administration.
    Hu Q; Prakash J; Rijcken CJ; Hennink WE; Storm G
    Int J Pharm; 2016 Nov; 514(1):112-120. PubMed ID: 27863654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
    Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
    Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.
    Danhier F; Danhier P; De Saedeleer CJ; Fruytier AC; Schleich N; des Rieux A; Sonveaux P; Gallez B; Préat V
    Int J Pharm; 2015 Feb; 479(2):399-407. PubMed ID: 25578367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
    Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel nanotechnology in anticancer therapy.
    Zhao P; Astruc D
    ChemMedChem; 2012 Jun; 7(6):952-72. PubMed ID: 22517723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.